Insiders Updates
A Guide To The Risks Of Investing In Solid Biosciences Inc (SLDB)
Solid Biosciences Inc’s filing revealed that its Director Kahn Clare acquired Company’s shares for reported $9924.0 on Mar 11 ’25.
Menu
Solid Biosciences Inc’s filing revealed that its Director Kahn Clare acquired Company’s shares for reported $9924.0 on Mar 11 ’25.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Solid Biosciences
Solid Biosciences Inc’s recent filing unveils that its Director Kahn Clare acquired Company’s shares for reported $9924.0 on Mar 11
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Solid Biosciences Inc’s recent filing unveils that its Director Kahn Clare acquired Company’s shares for reported $9924.0 on Mar 11
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Solid Biosciences Inc’s recent filing unveils that its Director Kahn Clare acquired Company’s shares for reported $9924.0 on Mar 11
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Solid Biosciences Inc’s recent filing unveils that its Director Kahn Clare acquired Company’s shares for reported $9924.0 on Mar 11
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or